Wednesday, May 14, 2025 | 10:59 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Serum Institute to make 100 mn more doses of Covid vaccine for Rs 250 each

Secures additional $150 mn risk funding from Bill and Melinda Gates Foundation

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das Mumbai
Pune-based Serum Institute of India (SII), the world’s largest vaccine maker by volume, will now be producing an additional 100 million Covid-19 vaccine doses for India as well as low- and medium-income countries (LMICs) in 2021. The vaccine will come for $3 or around Rs 250 per dose.
 
This would take the total volume of vaccines that SII will offer at this price to 200 million. The company has received an additional $150 million risk funding from the Bill and Melinda Gates Foundation. The announcement practically takes forward the collaboration among SII, Gavi, the Vaccine Alliance and Bill and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in